Insider Deck research · News

AMGN stock news · Amgen Inc.

Latest Amgen Inc. (AMGN) stock news, headlines, and research context on Insider Deck. Sector: Healthcare. Industry: Drug Manufacturers - General. Market cap $220B.

News desk

Amgen Inc. wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

10 on the wireUpdated within the hour

Zacks·Wed, Aug 5, 3:55 PM

AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure

Amgen beats Q2 earnings and revenue estimates and lifts its 2026 outlook. Key products witness strong growth despite biosimilar pressure on older drugs.

Insider Deck desk note

Last$407.83
Day+4.57%
SymbolAMGN

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on Zacks

Frequently asked questions

What is the latest news on AMGN?

The AMGN news desk aggregates recent headlines with research context for Amgen Inc. (Healthcare).

Where can I research AMGN on Insider Deck?

Amgen Inc. (AMGN) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.